Carequality Interoperability Framework expands with five new adopters

Carequality, an initiative of The Sequoia Project, announced five new adopters of the Carequality Interoperability Framework.

The companies are Coordinated Care Oklahoma, GE Healthcare, Kno2, Netsmart and OneRecord. The organizations join athenahealth, eClinicalWorks, Epic, NextGen Healthcare and Surescripts in contracting to implement the comprehensive framework.

Carequality is a multi-stakeholder initiative that has brought together public- and private-sector players to improve efforts to connect disparate networks and platforms.

“The diversity of organizations—from HIE to consumer access, large to small—adopting the Carequality Framework really highlights our vision for an interoperability framework that unites the entire healthcare continuum,” said Dave Cassel, director of Carequality, in a release. “Enabling patients and providers to access health records from the diverse participants in the Carequality ecosystem is a major step forward, not only for the healthcare experience but also for patient empowerment.”

 

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.